Elemene Antitumor Drugs Development Based on"Molecular Compatibility Theory" and Clinical Application:A Retrospective and Prospective Outlook
Back to article page
Herbal and Botanical Review|Updated:2023-12-20
|
Elemene Antitumor Drugs Development Based on"Molecular Compatibility Theory" and Clinical Application:A Retrospective and Prospective Outlook
Elemene Antitumor Drugs Development Based on"Molecular Compatibility Theory" and Clinical Application:A Retrospective and Prospective Outlook
中国结合医学杂志(英文版)2024年30卷第1期 页码:62-74
Affiliations:
1.School of Pharmacy, Hangzhou Normal University, Hangzhou(311121), China
2.Key Laboratory of Elemene Class Anti-cancer Chinese Medicines; Engineering Laboratory of Development and Application of Traditional Chinese Medicines; Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, Hangzhou Normal University, Hangzhou (311121),China
3.Good Clinical Practice Center, Affliliated Hospital of Nanjing University of Chinese Medicine, Nanjing (210000), China
Elemene Antitumor Drugs Development Based on"Molecular Compatibility Theory" and Clinical Application:A Retrospective and Prospective Outlook[J]. 中国结合医学杂志(英文版), 2024,30(1):62-74.
JIANG Xiao-ying, SHI Li-ping, ZHU Jun-long, et al. Elemene Antitumor Drugs Development Based on"Molecular Compatibility Theory" and Clinical Application:A Retrospective and Prospective Outlook[J]. Chinese Journal of Integrative Medicine, 2024,30(1):62-74.
Elemene Antitumor Drugs Development Based on"Molecular Compatibility Theory" and Clinical Application:A Retrospective and Prospective Outlook[J]. 中国结合医学杂志(英文版), 2024,30(1):62-74. DOI: 10.1007/s11655-023-3714-0.
JIANG Xiao-ying, SHI Li-ping, ZHU Jun-long, et al. Elemene Antitumor Drugs Development Based on"Molecular Compatibility Theory" and Clinical Application:A Retrospective and Prospective Outlook[J]. Chinese Journal of Integrative Medicine, 2024,30(1):62-74. DOI: 10.1007/s11655-023-3714-0.
Elemene Antitumor Drugs Development Based on"Molecular Compatibility Theory" and Clinical Application:A Retrospective and Prospective Outlook
摘要
Abstract
Elemene
derived from
Curcuma wenyujin
one of the "8 famous genuine medicinal materials of Zhejiang province
" exhibits remarkable antitumor activity. It has gained wide recognition in clinical practice for effectiveness on tumors. Dr. XIE Tian introduced the innovative concept of "molecular compatibility theory" by combining Chinese medicine principles
specifically the "monarch
minister
assistant
and envoy" theory
with modern biomedical technology. This groundbreaking approach
along with a systematic analysis of Chinese medicine and modern biomedical knowledge
led to the development of elemene nanoliposome formulations. These novel formulations offer numerous advantages
including low toxicity
well-defined composition
synergistic effects on multiple targets
and excellent biocompatibility. Following the principles of the "molecular compatibility theory"
further exploration of cancer treatment strategies and methods based on elemene was undertaken. This comprehensive review consolidates the current understanding of elemene's potential antitumor mechanisms
recent clinical investigations
advancements in drug delivery systems
and structural modifications. The ultimate goal of this review is to establish a solid theoretical foundation for researchers
empowering them to develop more effective antitumor drugs based on the principles of "molecular compatibility theory".